NicOx S.A. | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
436.00
5,982.00
9,963.00
16.00
15,080.00
4,717
Cost of Goods Sold (COGS) incl. D&A
685.00
4,713.00
5,982.00
-
12,946.00
826
Gross Income
249.00
1,269.00
3,981.00
16.00
2,134.00
3,891
SG&A Expense
15,194.00
28,721.00
31,008.00
20,785.00
19,458.00
25,701
EBIT
-
-
26,999.00
20,769.00
17,616.00
21,810
Unusual Expense
4,146.00
4,522.00
3,437.00
12,741.00
984.00
264
Non Operating Income/Expense
609.00
1,056.00
1,875.00
244.00
1,050.00
1,303
Interest Expense
10.00
687.00
70.00
107.00
18.00
71
Pretax Income
11,916.00
22,551.00
28,631.00
6,690.00
19,668.00
19,118
Income Tax
547.00
565.00
692.00
52.00
11,372.00
727
Consolidated Net Income
11,369.00
21,986.00
27,939.00
6,742.00
8,296.00
18,391
Net Income
11,369.00
21,986.00
27,939.00
6,742.00
8,296.00
18,391
Net Income After Extraordinaries
4,593.00
20,814.00
27,939.00
5,551.00
12,974.00
18,391
Net Income Available to Common
18,145.00
23,158.00
27,939.00
19,035.00
3,618.00
18,391
EPS (Basic)
1.25
7.15
1.25
0.80
0.13
0.62
Basic Shares Outstanding
14,615.60
3,244.50
22,355.40
-
26,954.50
29,602.20
EPS (Diluted)
1.24
7.14
1.25
-
0.13
0.62
Diluted Shares Outstanding
14,615.60
3,244.50
22,355.40
-
26,954.50
29,602.20
EBITDA
14,855.00
25,572.00
25,614.00
-
17,445.00
21,674
Other Operating Expense
-
10.00
28.00
-
292.00
-
Non-Operating Interest Income
-
-
-
1,202.00
-
1,724

About NicOx

View Profile
Address
Drakkar 2 - Bât D
Sophia-Antipolis Provence-Alpes-Cote-dAzur 06560
France
Employees -
Website http://www.nicox.com
Updated 07/08/2019
Nicox SA is an ophthalmology company, which engages in developing innovative solutions to help maintain vision and improve ocular health. Its products include Zerviate, and Vyzulta. The company was founded by Piero Del Soldato, Michele Garufi and Elizabeth Marie Robinson on February 15, 1996 and is headquartered in Sophia-Antipolis, France.